Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT02913794
Eligibility Criteria:
Inclusion Criteria:
* Hypertension patients who are taking an anti-hypertensive agent, including Fimasartan at least 12 weeks or more.
* Dyslipidemia patients who are taking dyslipidemia drug, including Rosuvastatin at least 12 weeks or more
* Patients who has blood pressure and lipid levels (Total cholesterol, LDL-C, HDL-C, non-HDL-C, \* TG) checks 2 weeks before registration
Exclusion Criteria:
* Patients being hospitalized
* Patients who stop taking Fimasartan or Rosuvastatin within 12 weeks 14 or more consecutive days
* Patients who have more than 400mg/dl triglyceride(TG) at the registration time
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT02913794
Study Brief:
Protocol Section:
NCT02913794